MedPath

Prevention of nausea and vomiting after surgery for stomach reduction in obese individuals.

Phase 4
Conditions
ausea and vomiting postoperativeObesity
C23.550.767.859
C18.654.726.500
Registration Number
RBR-4bxdhb
Lead Sponsor
niversidade Federal de Mato Grosso
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Patients aged between 18 and 65 years;
Obese patients with body mass index (BMI) greater than or equal 35 kg/m2;
Classified as physical status I-III of the American Society of Anesthesiologists (ASA);
Candidates for bariatric surgery, like laparoscopic sleeve gastrectomy under balanced general anesthesia

Exclusion Criteria

Hypersensitivity or contraindication to study drugs;
Serious complications in the perioperative period;
Psychiatric disorder and a history of migraine;
Used opóide, anti-inflammatory hormone and anti-emetic medication 24 hours prior to surgery

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath